NCT01215474View on ClinicalTrials.gov

Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC

CompletedOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

Not specified

Conditions

Mutations in Exons 18 to 21

Trial Locations (1)

10117

Institute of Pathology, Charité University Medicine Berlin, Berlin

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

collaborator

Charite University, Berlin, Germany

OTHER

lead

Provitro GmbH

INDUSTRY

NCT01215474 - Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC | Biotech Hunter | Biotech Hunter